Intramedullary Devices for the Treatment of Unstable Pertrochanteric

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the differences between two different types of devices for the treatment of unstable pertrochanteric hip fractures. The hypothesis of this study is, that patients who are treated with the proximal femoral Nail Antirotation (PFNA) have a better outcome and lower complication rates than patients treated with the Gamma Nail (GN3).

Clinical Trial Description

This trial is a prospective randomized controlled study including the treatment of AO/OTA 31-A2 fractures in 200 patients with 2 different surgical devices. 100 patients are treated with a Gamma Nail 3 (GN3) (Stryker) the other 100 patients with a Proximal Femoral Nail Antirotation (PFNA) (Synthes).

All surgeries are performed by trauma surgeons at a Level 1 University Hospital. One hundred patients are randomized to the gamma nail and 100 are randomized to the proximal femoral nail for treatment fixation. A 1:1 randomization is performed using sealed envelopes (200 in total), which are opened by the surgeon immediately before the operation.

Patients missing an informed consent form, incomplete chart, or showing a pathologic fracture are getting excluded from final comparisons.

Patients anthropometric data as well as pre-injury mobility assessments, and ASA will be documented. Furthermore the time from admission to going to surgery, surgery length, length of stay and mobility assessment at dischargement are recorded.

After surgery the stay in the hospital is documented precisely and patients are scheduled for next appointments 2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery.

Postoperative X-rays are measured precisely to determine the Tip-Apex Distance (TAD), the Parkers-Ratio, the Singh-Score and the Neck-Shaft-Angle of the injured and contralateral side. Rates of complications as cut-out and reoperation-rates are evaluated. All intra-operative complications are noted and included in the chart. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02074969
Study type	Interventional
Source	Medical University of Vienna
Contact
Status	Completed
Phase	N/A
Start date	October 2007
Completion date	May 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00137085` - Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation	N/A
Completed	`NCT00235404` - Randomized Controlled Trial of Health Care to Elderly Patients.	N/A
Completed	`NCT00152321` - Strategies Targeting Osteoporosis to Prevent Recurrent Fractures	N/A
Completed	`NCT01127711` - Cohort of Swedish Men	N/A
Completed	`NCT00060970` - Evaluating Muscle Function After Ankle Surgery	N/A
Completed	`NCT02576730` - Functional Outcome Assessment After (Calcaneal) Trauma Surgey	N/A
Completed	`NCT00767780` - The Effect of a New Biomechanical Device	N/A
Withdrawn	`NCT00355420` - Evaluation of the Change in Length of the Leg in Children After Treatment of Femur Fractures.	Phase 2
Completed	`NCT00129142` - Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy	Phase 3
Recruiting	`NCT03367169` - Surgery of the Pilon Fractures	N/A
Active, not recruiting	`NCT01452243` - Prevention of Falls and Fractures in Old People by Administration of Calcium and Vitamin D. Randomized Clinical Trial	Phase 3
Completed	`NCT00545350` - Exercise Intervention to Prevent Fall-related Fractures and Other Injuries : The Ossébo Study	N/A
Terminated	`NCT00387686` - A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures	Phase 2/Phase 3
Completed	`NCT02292316` - Falls With Fracture : Role of Cognitive Disorders and Comparison With Bone Fragility	N/A
Completed	`NCT01136616` - CT Analysis of Structural Buttresses in the Traumatised Nose	Phase 2
Completed	`NCT02090972` - The Impact of Opioids in Fractures - a Case Control Study	N/A
Recruiting	`NCT02237040` - A New Treatment Protocol for Paediatric Mandibular Condylar Fractures	N/A
Completed	`NCT00872105` - Conservative Treatment Versus Operative Plate Fixation for Acute, Displaced Fractures of the Distal Clavicle	N/A
Completed	`NCT00652548` - Use of Ultrasound to Evaluate Clavicle Fractures in Pediatric Patients	N/A
Completed	`NCT00079521` - Therapeutic Touch for Wrist Fractures in Postmenopausal Women	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms